Such conversations are becoming increasingly common as demand for weight-loss drugs explodes in urban India - a country with ...

From discontinued insulin pens to overpriced TB drugs, meet the young South African holding drug makers to account on behalf of patients.

Telehealth company Hims & Hers Health Inc. said late Monday it is in "active discussions" with Denmark's Novo Nordisk A/S to make Wegovy available on its platform.

Hims & Hers said that the discussions with Novo Nordisk (DK:NOVO.B) are ongoing, that "no definitive agreement" has been reached, and that the two companies may not reach one. Nonetheless, Hims & Hers ...

The latest buyout Novo Nordisk is trying to pull off is putting it in a direct confrontation with another beaten-down pharmaceutical giant: Pfizer (NYSE: PFE). Let's see what's happening between these ...

Neurocrine Biosciences has penned a deal with China’s TransThera Sciences potentially worth more than $880 million in ...

Novo Nordisk attempts to acquire weight-loss drug company Metsera during government shutdown, potentially avoiding FTC antitrust review and regulatory scrutiny.

Lilly’s quarterly results Thursday, combined with Novo Nordisk’s unsolicited offer for a startup, confirm the $72 billion ...

Novo Nordisk's VP Dorethe Nielsen introduces the 'Suppliers for Zero' plan to help the firm meet its climate and nature goals ...

The Wegovy and Ozempic maker’s offer comes after Pfizer last month agreed to a lower deal to acquire the Nasdaq-listed ...